ask="6.800"
ask_size="100"
average_daily_volume="164778"
bid="2.000"
bid_size="400"
book_value="0.000"
change="+0.182"
change_from_200_day_moving_average="-1.487"
change_from_50_day_moving_average="-1.350"
change_from_52_week_high="-6.228"
change_From_52_week_low="0.442"
change_in_percent="+5.498%"
close="3.492"
dividend_pay_date="8/1/2016"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.175"
ebitda="0.00"
eps_estimate_current_year="-3.640"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-2.250"
ex_dividend_date="N/A"
float_shares="N/A"
high="3.700"
high_52_weeks="9.720"
last_trade_date="3/3/2017"
last_trade_price="3.492"
last_trade_size="1000"
last_trade_time="3:56pm"
low="3.310"
low_52_weeks="3.050"
market_capitalization="N/A"
moving_average_200_day="4.979"
moving_average_50_day="4.842"
name="Cyclacel Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.000"
open="3.310"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-29.863%"
percent_change_from_50_day_moving_average="-27.877%"
percent_change_from_52_week_high="-64.074%"
percent_change_from_52_week_low="+14.492%"
previous_close="3.310"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.000"
stock_exchange="NCM"
symbol="CYCC"
volume="60219"
weeks_range_52="3.050 - 9.720"
